KALA BIO
IPOPublic · Arlington, United States · $113.2M raised
- Headquarters
- Arlington, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- kalarx.com
- Total Funding
- $113.2M
- Last Round
- $68.0M Series CApr 2016
- Rounds
- 4
- Type
- Public
About
KALA BIO is a clinical-stage biopharmaceutical company focused on developing treatments for rare and serious eye diseases.
Summary
KALA BIO is a Biotech company based in Arlington, United States. It has raised $113.2M in total across 4 rounds, most recently a $68.0M Series C round in Apr 2016. Investors include OrbiMed, Ysios Capital and Third Rock Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2017
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company